Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

Link:
Autor/in:
Erscheinungsjahr:
2011
Medientyp:
Text
Schlagworte:
  • Adult
  • Humans
  • Male
  • Cohort Studies
  • Lymphatic Metastasis
  • Prognosis
  • Survival Rate
  • Follow-Up Studies
  • Postoperative Complications
  • Neoplasm Staging
  • United States/epidemiology
  • Lymph Node Excision/*utilization
  • Mortality/*trends
  • Neoplasms, Germ Cell and Embryonal/*epidemiology/mortality/*surgery
  • Retroperitoneal Space/*surgery
  • SEER Program
  • Testicular Neoplasms/*epidemiology/mortality/*surgery
  • Adult
  • Humans
  • Male
  • Cohort Studies
  • Lymphatic Metastasis
  • Prognosis
  • Survival Rate
  • Follow-Up Studies
  • Postoperative Complications
  • Neoplasm Staging
  • United States/epidemiology
  • Lymph Node Excision/*utilization
  • Mortality/*trends
  • Neoplasms, Germ Cell and Embryonal/*epidemiology/mortality/*surgery
  • Retroperitoneal Space/*surgery
  • SEER Program
  • Testicular Neoplasms/*epidemiology/mortality/*surgery
Beschreibung:
  • Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.
  • Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.
Lizenz:
  • info:eu-repo/semantics/restrictedAccess
Quellsystem:
Forschungsinformationssystem des UKE

Interne Metadaten
Quelldatensatz
oai:pure.atira.dk:publications/4b1d9c41-71fc-4c30-8c86-3706d2179f5e